In the Press
Advaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure
GPU-Accelerated Platform Unifies Fragmented Workflows, Turning Weeks of Analysis into Minutes ANN ARBOR, MI, May 7, 2026 /PRNewswire/-- Advaita Bio today announced the launch of iSCanGuide™, a cloud-based platform engineered to transform large-scale single-cell and spatial transcriptomics datasets into biologically meaningful results. Built on 20 years of validated science, the platform is integrated with Advaita’s flagship platform, iPathwayGuide™TM, replacing fragmented workflows with a unified, GPU-powered discovery environment. Single-cell and spatial transcriptomics generate complex datasets — but most researchers are still stitching together fragmented tools to analyze them, writing custom scripts, exporting between platforms, and losing weeks to manual workflows. [...]
Advaita Bio awarded $1.7 million NIH study to pioneer platform for the analysis of single-cell data
This award will be used to develop advanced methods for the analysis of single cell and spatial genomics and transcriptomics data, while providing life scientists a platform that can provide a one- stop solution that implements the best practices. Ann Arbor, Michigan, January 30, 2024 Advaita Bio was awarded $1.7 million from the National Institute of Health (NIH) to develop a new platform for the analysis of single-cell data. AdvaitaBio is the leader in the interpretation of high- throughput biomedical data including variant interpretation, pathway analysis, disease subtype discovery, single cell analysis, and integration across multiple data types. This research [...]
iPathwayGuide™’s prediction for a COVID-19 drug validated, peer-reviewed and published!
Methylprednisolone effective in treating critically ill patients Almost exactly one year ago, the US was experiencing the first wave of COVID-19. In March 2020, SARS-CoV2 is defying all modern medical knowledge and technology killing people at a rate of 1,500 daily, in US alone. WHO recommends against use of steroids for COVID-19 patients. At about the same time, the first mRNA datasets characterizing the blood transcriptome in severe cases becomes available. A couple of days later, iPathwayGuide™ identifies several existing drugs that are predicted to help in severe cases. The top drug is methylprednisolone (MP) which contradicts flagrantly the WHO recommendations. Interestingly, not [...]
Advaita’s iPathwayGuide™ provides a cost-effective alternative to Ingenuity Pathway Analysis (IPA) on Yet Another Continent
Inqaba Biotechnical Industries partners with Advaita Bioinformatics to provide advanced pathway analysis software in Sub-Saharan AfricaANN ARBOR, MI – October 14, 2019— Advaita Bioinformatics, the leader in the interpretation of high-throughput biomedical data, today announced a new distribution partnership with Inqaba Biotechnical Industries. inqaba biotec chose Advaita’s iPathwayGuide™ and iVariantGuide to better serve their customers as well as for their in-house needs."This much-welcomed partnership will serve our growing customer base with their ever-increasing need for superior data analysis. This is what our customers demand," said Bioinformatics Solutions Manager at inqaba biotec, Dr. Hamilton Ganesan. He went on to say, "Advaita’s [...]